InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Benitec Biopharma Inc.

BNTC Clue Score32
United States Fiscal year ends June CIK 0001808898
$8.87 +1.37% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $8.87 +151.27% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 11 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2019Revenue12.2Operating income2.6Net income2.6Fiscal year 2020Revenue0.1 −99.2%Operating income−8.3Net income−8.3 −417.1%Fiscal year 2021Revenue0.1 −42.2%Operating income−13.6Net income−13.9EPS, diluted−3.23Fiscal year 2022Revenue0.1 +23.7%Operating income−17.9Net income−18.2EPS, diluted−37.88Fiscal year 2023Revenue0.1 +2.7%Operating income−19.1Net income−19.6EPS, diluted−14.12Fiscal year 2024Revenue0.0 −100.0%Operating income−22.5Net income−21.8EPS, diluted−1.22Fiscal year 2025Operating income−41.8Net income−37.9EPS, diluted−1.05Fiscal year 2026Operating income−51.2Net income−45.5EPS, diluted−0.98
FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue 12.2 0.1 0.1 0.1 0.1 0.0 n/a n/a
Growth −99.2% −42.2% +23.7% +2.7% −100.0%
Operating income 2.6 −8.3 −13.6 −17.9 −19.1 −22.5 −41.8 −51.2
Net income 2.6 −8.3 −13.9 −18.2 −19.6 −21.8 −37.9 −45.5
Growth −417.1%
EPS, diluted n/a n/a −3.23 −37.88 −14.12 −1.22 −1.05 −0.98

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2019Operating margin21.2%Net margin21.4%Free cash flow margin36.0%Fiscal year 2020Operating margin−8,118.6%Net margin−8,111.8%Free cash flow margin−7,480.4%Fiscal year 2021Operating margin−23,044.1%Net margin−23,528.8%Free cash flow margin−22,123.7%Fiscal year 2022Operating margin−24,457.5%Net margin−24,942.5%Free cash flow margin−21,797.3%Fiscal year 2023Operating margin−25,441.3%Net margin−26,082.7%Free cash flow margin−24,017.3%Fiscal year 2024Fiscal year 2025Fiscal year 2026
FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Operating margin 21.2% −8,118.6% −23,044.1% −24,457.5% −25,441.3% n/a n/a n/a
Net margin 21.4% −8,111.8% −23,528.8% −24,942.5% −26,082.7% n/a n/a n/a
Free cash flow margin 36.0% −7,480.4% −22,123.7% −21,797.3% −24,017.3% n/a n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2019Operating cash flow4.8Capital expenditure−0.4Free cash flow4.4Fiscal year 2020Operating cash flow−7.5Capital expenditure−0.1Free cash flow−7.6 −274.0%Fiscal year 2021Operating cash flow−12.8Capital expenditure−0.2Free cash flow−13.1Fiscal year 2022Operating cash flow−15.9Capital expenditure−0.0Free cash flow−15.9Fiscal year 2023Operating cash flow−18.0Capital expenditure−0.0Free cash flow−18.0Fiscal year 2024Operating cash flow−19.4Capital expenditure−0.2Free cash flow−19.6Fiscal year 2025Operating cash flow−23.6Capital expenditure−0.0Free cash flow−23.6Fiscal year 2026Operating cash flow−16.5Capital expenditure−0.1Free cash flow−16.6
FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Operating cash flow 4.8 −7.5 −12.8 −15.9 −18.0 −19.4 −23.6 −16.5
Capital expenditure −0.4 −0.1 −0.2 −0.0 −0.0 −0.2 −0.0 −0.1
Free cash flow 4.4 −7.6 −13.1 −15.9 −18.0 −19.6 −23.6 −16.6
Growth −274.0%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2019Cash15.7Shareholders’ equity16.6Fiscal year 2020Cash9.8Shareholders’ equity10.2Fiscal year 2021Cash19.8Shareholders’ equity20.0Fiscal year 2022Cash4.1Shareholders’ equity2.9Fiscal year 2023Cash2.5Shareholders’ equity0.2Fiscal year 2024Cash50.9Shareholders’ equity47.2Fiscal year 2025Cash97.7Shareholders’ equity97.3Fiscal year 2026Cash180.0Shareholders’ equity177.0
FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash 15.7 9.8 19.8 4.1 2.5 50.9 97.7 180.0
Shareholders’ equity 16.6 10.2 20.0 2.9 0.2 47.2 97.3 177.0

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2026 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending June, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2019 30 Jun 2019 FY2020 30 Jun 2020 FY2021 30 Jun 2021 FY2022† 30 Jun 2022 FY2023† 30 Jun 2023 FY2024† 30 Jun 2024 FY2025† 30 Jun 2025 FY2026 30 Jun 2026
Revenue and profit
12.2 0.1 0.1 0.1 0.1 0.0 n/a n/a
Growth −99.2% −42.2% +23.7% +2.7% −100.0%
4.6 3.0 7.0 11.3 12.8 15.6 18.3 23.4
4.6 5.6 6.5 6.6 6.4 7.0 23.4 27.8
2.6 −8.3 −13.6 −17.9 −19.1 −22.5 −41.8 −51.2
Growth −420.6%
n/a n/a n/a n/a n/a n/a n/a 0.0
2.6 −8.3 −13.9 −18.2 −19.6 −21.8 −37.9 −45.5
Growth −417.1%
Per share
n/a n/a −3.23 −37.88 −14.12 −1.22 −1.05 −0.98
n/a n/a −3.23 −37.88 −14.12 −1.22 −1.05 −0.98
Growth
n/a n/a 4.3 0.5 1.4 18.4 36.2 46.6
n/a n/a 4.3 0.5 1.4 18.4 36.2 46.6
Growth −88.8% +188.3% +1,225.2% +97.2% +28.6%

† The diluted share count jumps at 2022 and 2023 and 2024 and 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 7 of 8 years on file.